DESIGNED WITH PURPOSE
A-CIFT SoloFuse-P Standalone Less Exposure Surgery System was intentionally designed to leverage the familiarity of existing techniques while providing an alternative to cumbersome plating for one-level procedures. Its simplicity of design makes for a straightforward implantation that minimizes tissue disruption.
Click number to view featured highlight.
HOW SOLOFUSE INNOVATES
A-CIFT SoloFuse-P provides stability and fixation to the vertebral body. Its zero profile and all PEEK-OPTIMA Natural design allows the interbody to sit flush with the anterior face of the vertebrae, thereby minimizing tissue disruption. Its slim instrumentation is ideal for delivering the interbody at tight levels and through small incisions.
A dual-screw construct offers a sleeker and more facile alternative to bulkier, three-screw designs. The simplicity of design makes for a straightforward implantation.
A-CIFT SoloFuse-P leverages the familiarity of existing techniques while providing an alternative to cumbersome plating for one-level procedures. Its standalone design makes implantation easier.
LARGE GRAFT VOLUME
The A-CIFT SoloFuse-P has a large graft window that allows for higher volume of bone graft for bony fusion.
Lag screws aid in compression, enhancing surgeon control over vertebral contact.
The zero-profile and PEEK-OPTIMA Natural design allows A-CIFT SoloFuse-P to sit flush with the anterior face of the vertebrae, thereby minimizing tissue disruption.
SOLOFUSE ADOPTION DATA
days on the market
implants sold & used
CASE STUDIES & RESEARCH
The A-CIFT™ SoloFuse™-P Cervical Intervertebral Fusion Device System is intended for stand-alone use for intervertebral body fusion of the spine of skeletally mature patients, using autogenous bone graft to facilitate fusion. The A-CIFT™ SoloFuse™-P system must be used with the internal bone screws for fixation. The device is indicated for use in patients with degenerative disc disease (DDD) of the cervical spine at one level from the C2-C3 disc to the C7-T1 disc. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). Degenerative Disc Disease is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six (6) weeks of non-operative treatment prior to the treatment with an intervertebral spacer.